Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander J Thompson

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2015
Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varicesNik S Ding, Tin Nguyen, David M Iser, et al.
Plos One|July 18, 2018
No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis BLai Wei, Heiner Wedemeyer, Yun-Fan Liaw, et al.
The Medical Journal of Australia|March 15, 2023
Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facilityMichael B MacIsaac, Bradley Whitton, Adrian Hubble, et al.
Inflammatory Bowel Diseases|March 11, 2021
A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to ConceiveEmma Flanagan, Emily K Wright, Miles P Sparrow, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2025
Long-Term Follow-Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg LossSimon J Hume, Samuel Hall, Gareth Burns, et al.
Transplantation|February 24, 2015
Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody MicroarraysWassim Rahman, Thomas Tu, Magdalena Budzinska, et al.
Journal of Gastroenterology and Hepatology|March 18, 2011
Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patientsKeyur Patel, Alexander J Thompson, Wan-Long Chuang, et al.
The International Journal on Drug Policy|January 28, 2024
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facilityMichael B MacIsaac, Bradley Whitton, Jenine Anderson, et al.
Journal of Virology|November 11, 2011
Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative diseaseChristopher P Desmond, Silvana Gaudieri, Ian R James, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2015
Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varicesNik S Ding, Tin Nguyen, David M Iser, et al.
Plos One|July 18, 2018
No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis BLai Wei, Heiner Wedemeyer, Yun-Fan Liaw, et al.
The Medical Journal of Australia|March 15, 2023
Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facilityMichael B MacIsaac, Bradley Whitton, Adrian Hubble, et al.
Inflammatory Bowel Diseases|March 11, 2021
A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to ConceiveEmma Flanagan, Emily K Wright, Miles P Sparrow, et al.
Hepatology (Baltimore, Md.)|January 23, 2014
ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological responseJacinta A Holmes, Stuart K Roberts, Rachel J Ali, et al.
Alimentary Pharmacology & Therapeutics|August 22, 2025
Long-Term Follow-Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg LossSimon J Hume, Samuel Hall, Gareth Burns, et al.
Transplantation|February 24, 2015
Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody MicroarraysWassim Rahman, Thomas Tu, Magdalena Budzinska, et al.
Journal of Gastroenterology and Hepatology|March 18, 2011
Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patientsKeyur Patel, Alexander J Thompson, Wan-Long Chuang, et al.
The International Journal on Drug Policy|January 28, 2024
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facilityMichael B MacIsaac, Bradley Whitton, Jenine Anderson, et al.
Journal of Virology|November 11, 2011
Viral adaptation to host immune responses occurs in chronic hepatitis B virus (HBV) infection, and adaptation is greatest in HBV e antigen-negative diseaseChristopher P Desmond, Silvana Gaudieri, Ian R James, et al.
Pageof 18